ADVERTISEMENT
Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
May 2023
Preview This Issue
Archives
Features
Quarterly Magazine
Current Issue
Summer 2023
Preview This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Webinars
ADVERTISEMENT
Home
Subjects
personal omics
personal omics
23andMe Markets Genome Kits to Researchers
Kerry Grens
| Jul 14, 2016
| 1 min read
Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens
| Oct 21, 2015
| 2 min read
The personal genomics firm is ramping up its suite of disease-related genetic tests.
Venter Enters the Consumer Genomics Biz
Bob Grant
| Sep 22, 2015
| 2 min read
The genomic entrepreneur has struck a deal with a South African health insurer to sequence the exomes of its customers.
Direct-to-Consumer Liquid Biopsy
Kerry Grens
| Sep 13, 2015
| 2 min read
Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.
Illumina, Investors Launch Consumer Genetics Firm
Tracy Vence
| Aug 19, 2015
| 1 min read
With $100 million in initial funding, Helix aims to make personal genomics accessible.
23andMe Enters Drug Development
Kerry Grens
| Mar 12, 2015
| 2 min read
The personal genomics firm announces plans to make medicines.
FDA OKs 23andMe Test
Kerry Grens
| Feb 20, 2015
| 1 min read
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
23andMe Partners with Pfizer
Jef Akst
| Jan 13, 2015
| 1 min read
The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.
23andMe Expands to U.K.
Kerry Grens
| Dec 2, 2014
| 1 min read
British consumers can buy the genetic testing-associated health prediction service forbidden by the US government.
On Race and Medicine
Keith Norris
| Feb 1, 2014
| 4 min read
Until health care becomes truly personalized, race and ethnicity will continue to be important clues guiding medical treatments.
$1,000 Genome at Last?
Tracy Vence
| Jan 15, 2014
| 2 min read
Illumina says its newest sequencing system can churn out whole human genomes for $1,000 apiece.
GeneLink Settles
Abby Olena, PhD
| Jan 14, 2014
| 2 min read
Another personal genomics company faces government pressure—this time from the Federal Trade Commission.
Speaking of Science
The Scientist
Staff
| Jan 1, 2014
| 2 min read
January 2014's selection of notable quotes
23andMe Steps Back
Abby Olena, PhD
| Dec 6, 2013
| 2 min read
The company announces that it will stop offering health interpretations of personal genetic data.
23andMe Now Facing Lawsuit
Kerry Grens
| Dec 4, 2013
| 1 min read
Shortly after getting in trouble with the Food and Drug Administration, the personal genetic testing company is slapped with a class action lawsuit.
FDA to 23andMe: Stop Marketing Kits
Kerry Grens
| Nov 26, 2013
| 2 min read
The US Food and Drug Administration blocks the marketing of unapproved genetic tests.
Genetics Firm Gets Baby-Predicting Patent
Bob Grant
| Oct 4, 2013
| 3 min read
23andMe denies that its new patent will be used to help couples create designer babies based on personal genetic testing.
N=Me
Kerry Grens
| Aug 1, 2013
| 4 min read
Science gets personal as researchers—professional and amateur—plumb the depths of their own molecular biology.
Track Thyself
Kerry Grens
| Jul 31, 2013
| 1 min read
Meet Larry Smarr, a UC San Diego computer scientist who records several facets of his physiology, on the hunt for signs of present or future health problems.
ADVERTISEMENT